In April 2010, the FDA sent Buttar a
warning letter for illegally marketing unapproved topical creams as drugs via his websites, YouTube videos, and radio appearances.
[4][5] FDA inspections also revealed that Buttar’s company, V-SAB Medical Labs, had not complied with
good manufacturing practices and that its products were “adulterated” according to the
Federal Food, Drug, and Cosmetic Act.
[6]
In 2011, as a result of the disciplinary action in North Carolina, the Hawaii Medical Board denied Buttar a medical license.
[23]
In 2019, the North Carolina Medical Board disciplined Buttar after receiving two complaints. In one case, a physician was worried that Buttar's treatment of a cancer patient hindered appropriate treatment and increased the patient's pain and suffering. In the other case, Buttar admitted that his personal relationship with the parent of a young patient constituted a boundary violation. Buttar and the Medical Board settled the complaints in a Consent Order that included a reprimand and a requirement to take courses in ethics and record keeping. Buttar acknowledged that his conduct constituted "unprofessional conduct including, but not limited to, departure from or the failure to conform to the ethics of the profession." Additionally, regarding the cancer patient, Buttar acknowledged that his documentation of care "failed to conform to the standards of acceptable and prevailing medical practice".
[3]
